Logos Global Management’s Relmada Therapeutics RLMD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-400,000	Closed	-$9.01M	–	61
2021 Q4	$9.01M	Buy	+400,000	New	+$9.01M	0.93%	28